Information  X 
Enter a valid email address

Synairgen PLC Ord 1P (SNG)

Related News

29-Jul-2010 12:35 PM

Synairgen loss edges up

Respiratory drug developer Synairgen reported a pre-tax loss of £2.9m for the year to June 30, up from £2.8m. Research and development expenditure for the year was unchanged at £2.1m. Cash at 30 June was £5.0, down from £7.9m a year ago. Chairman Simon
27-Jul-2010 09:01 AM

Synairgen finals this week

Respiratory drug discovery and development company Synairgen will announce its results for the year to June 30 on Thursday (July 29). Story provided by
17-May-2010 08:18 AM

Synairgen flu drug progress

AIM-listed Synairgen plc, the drug discovery company, has revealed promising data from SNG001, it inhaled interferon beta product, in a new model of influenza. Data from its new in vitro lung re-infection model shows for the first time that SNG001 can pr
01-Apr-2010 08:34 AM

Synairgen starts Phase II trial of IFN-beta

Respiratory drug developer Synairgen has started a Phase II study of its IFN-beta asthma treatment. The trial is expected to be completed during summer 2011. CEO Richard Marsden said, 'We are delighted to have been able to commence this study on s
08-Feb-2010 10:56 AM

Synairgen H1 loss £1.21m vs £1,14m

Respiratory drug developer Synairgen reported a post-tax loss for the six months to December of £1.21m, against a previous £1.14m. The company finished the half with net funds of £6.84m, up from £3.02m following an equity issue in June. R&D expenditur
12-Nov-2009 10:08 AM

Synairgen welcomes IFN-beta results

Respiratory company Synairgen has announced a successful Phase I clinical study for IFN-beta, its treatment of viral infection in asthma and COPD sufferers. The study aimed to assess the safety of the treatment and establish it activates antiviral def...
09-Nov-2009 09:28 AM

Tests show Synairgen treatment combats swine flu

Drug developer Synairgen says laboratory experiments have confirmed the potency of its interferon beta asthma therapy against swine flu. In the experiments by the Health Protection Agency at Porton Down, the proportion of cells infected with the virus w...
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t